Entering text into the input field will update the search result below

Aphria Deutschland receives fifth cultivation license in Germany

  • Aphria's (APHA) German subsidiary Aphria Deutschland GmbH had been awarded a fifth lot for the cultivation of medical cannabis in Germany as part of license from the German Federal Institute for Drugs and Medical Devices ("BfArM").
  • With this decision, Aphria Germany won the maximum output from the German tender process and becomes the only licensed producer permitted to cultivate all three approved strains of medical cannabis in Germany.

Recommended For You

Related Stocks

SymbolLast Price% Chg
TLRY
--
TLRY:CA
--